Cancer Research

Five New Mesothelioma Research Projects Funded

We are pleased to announce the funding of five new mesothelioma research projects by the Meso Foundation. To date the Meso Foundation has funded 99 projects amounting to over $9.4 million awarded toward mesothelioma research.
The Meso Foundation’s research program follows a rigorous peer-review system modeled after that of the National Institutes of Health. Each year, […]



New Search Tool Allows Easy Navigation of Funded Research Projects

This week, we announced the release of a search tool which will enable users on the Meso Foundation’s website to easily search through nearly 100 mesothelioma research projects the organization has funded since its inception.
“As we continue funding important research, it has become very important to create easy ways to sort through that research,” said […]


BREAKING NEWS: Data Released from Anetumab Ravtansine Study

Last week, at the World Conference on Lung Cancer, Dr. Raffit Hassan presented promising data on a novel agent, anetumab ravtansine, also known as BAY 94-9343. Anetumab ravtansine is an antibody-drug conjugate directed against the target molecule mesothelin which is highly expressed on mesotheliomas.
“Anetumab ravtansine shows encouraging efficacy in patients with advanced mesothelioma which warrants […]


Updates from ASCO: CRS-207 Vaccine Study Results

Aduro BioTech is conducting a clinical trial to test an investigational new immunotherapy for malignant pleural mesothelioma (MPM). This therapy, called CRS-207, is given to a patient in combination with chemotherapy in hopes of encouraging the body’s normal defense mechanisms to fight off the cancer. This trial aims to enroll up to 60 patients at […]